December 2013

MesoRFA Newsletter: Winter 2013 Edition

Message from Executive Director, Birdslanding event review, Annual golf invitational review, Roger Hamilton Memorial review, John S. Lyons Memorial review, S. California Pipetrades event review, and California Bio-Pharma review.

read more...


November 15, 2013

PhRMA Golf Invitational

MesoRFA is blessed with the efforts of the Autumn 2013 fundraising. The Pharmaceutical Research and Manufacturers of America and the California State Building and Construction Trades make MesoRFA the benefactor of donations which go towards mesothelioma research!

read more...


October 28, 2013

Autumn 2013 - District Council 16 Aim to Cure

The Southern California Pipetrades District Council 16 organizes a wonderful event to help find a cure for mesothelioma. The Aim to Cure event, held at the Moore 'N Moore Sporting Clays facility, generated approximately $25,000 for mesothelioma research!

read more...


September 7, 2013

John S. Lyons Memorial Banquet

For the 31st consecutive year "The JOHNS" and supporters joined to raise money at their Annual Memorial Banquet. Along with the Salk Institute and the Epilepsy Foundation, The Mesothelioma Research Foundation of America was honored to be chosen as one of the benefactors of this year’s event, while also honoring 2013 Labor Leader, Johnny Simpson, and others.

read more...


Bring your questions to Dr. Gill: click HERE

DONATIONS for cancer cure

100 percent of all proceeds received are going to the USC Norris Comprehensive Cancer Medical Center in Los Angeles to support the FDA Phase III of Dr. Gill's clinical trials. These trials are for Veglin, a mesothelioma cancer treatment. Veglin manipulates the blood vessels to starve a malignant tumor while alleviating fluid build up in the lungs

Support the hope in this research and click HERE


Patient Assistance Programs are offered by many pharmaceutical manufacturers to help pay for medications. These offers are sometimes called Indigent Drug Programs. Use our link just following, and learn whether a specific drug might be available at reduced cost or for free.

Drug Assistance Programs: click HERE

At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of the pharmaceutical company that makes the drug you are using


Find the lastest Mesothelioma clinical trials: click HERE

To ask Dr. Gill a question: click HERE

Help this Foundation and click HERE


Cancer imposes heavy economic burdens on a cancer patients and family members alike. Resources are available for individuals who do not have health insurance or who need financial assistance to cover health care costs. Our listing will help you find Government agencies, private organizations, and programs that are designed to provide assistance for a cancer patient and their family.

Financial help for cancer patients: click HERE

At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of organizations that provide financial assistance.

Bring your questions to Dr. Gill: click HERE

Help grow the Foundation and cancer-cure research: click HERE

Pause
Resume

Clinical Trials Status

Dr. Parkash Gill, M.D.
Dr. Parkash Gill

 

Dr. Parkash Gill of the USC Norris Comprehensive Cancer Center has announced that the new cancer fighting drug EPH-B4 has been submitted to the FDA for Phase I Clinical Trials and is available to qualifying mesothelioma patients. In the initial Phase I Trial EPH-B4 is available to newly diagnosed patients who have not undergone any conventional treatment options and to those patients who have exhausted all other treatment options such as surgery and chemotherapy. This is truly exciting as Dr. Gill has reported that EPH-B4 has shown great promise as a solo treatment or in conjunction with other drugs as Alimta, Cisplatin and Carboplatin.


Please use our FaceBook link to obtain your FREE copy of our eBook that teaches:

10 Easy Steps On How To Find And Choose A Clinical Trial For Mesothelioma And How To Prepare For It!

Ask Dr. Gill about your specific mesothelioma issues here: Ask Dr. Gill

In addition to the eBook found at our Facebook fan page, also learn more about clinical trials from these links:


February 15, 2014

There have been significant improvements creating new options for patients with Mesothelioma lung cancer. This video presents the new options for a patient to be aware of and consider. This news release video, created by Med Page Today, is about Oncology and Lung Cancer has been shared on YouTube by the Mesothelioma Research Foundation of America.

 

 


Lyons Foundation Chooses MesoRFA

The Mesothelioma Research Foundation of America is the proud recipient of a grant from the John S. Lyons Memorial Foundation, charitable branch of the San Diego Building Trades Councel, to help support clinical studies of Dr. Parkash Gill's protein known as EPH B4 as a mesothelioma cancer treatment option.

John S. Lyons Memorial Foundation

Read More...


THE FOUNDATION

The Mesothelioma Research Foundation of America has a mission: fund research that will lead to the quickest cure for mesothelioma. Mesothelioma is a cancer of the lining of the lungs caused by asbestos exposure. This cancer disease had few treatment options until this Foundation and Dr. Parkash Gill's work created better treatment options. Today, the future looks more hopeful for additional improved treatment options available to those stricken by this cancer.

James W. Kellogg, Jerry Neil Paul, Elizabeth Paul and Dr. Parkash Gill, M.D.
The Foundation Board Members from the left are: James W. Kellogg, Jerry Neil Paul, Elizabeth Ann Paul and Dr. Parkash Gill, M.D. These are respectively the United Association International Representative, Founding Director, Executive Director and Chairman of the Medical Advisory Board.

 

The Mesothelioma Research Foundation of America began funding research for a cure in 2001 with the opening of the Mesothelioma Laboratory at USC Norris Comprehensive Cancer Medical Center in Los Angeles under the supervision of Dr. Parkash Gill.

Dr. Gill is a board certified oncologist and hematologist who has received FDA approval from the U.S. Government to do Clinical Trials on a mesothelioma treatment drug called Veglin. We believe there is great promise and hope in Veglin and the Mesothelioma Research Foundation of America has funded 100% of Dr. Gill's research.

Veglin proved successful in Phase I and Phase II clinical trials. Many are very hopeful for the possibilities of a more effective cancer treatment compared to what presently is available for mesothelioma victims. We are currently waiting for further FDA approval to begin Veglin as soon as possible.

Top of Page